University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Items where Author is "Ilett, E"

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 17.

Article

Kottke, Tim, Evgin, Laura, Shim, Kevin G., Rommelfanger, Diana, Boisgerault, Nicolas, Zaidi, Shane, Diaz, Rosa Maria, Thompson, Jill, Ilett, Elizabeth, Coffey, Matt, Selby, Peter, Pandha, Hardev, Harrington, Kevin, Melcher, Alan and Vile, Richard (2017) Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence Cancer Immunology Research, 5 (11). pp. 1029-1045.

Zaidi, S, Blanchard, M, Shim, K, Ilett, E, Rajani, K, Parrish, C, Boisgerault, N, Kottke, T, Thompson, J, Celis, E, Pulido, J, Selby, P, Pandha, H, Melcher, A, Harrington, K and Vile, R (2015) Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine melanoma Model After Treatment With Immunomodulatory Agents MOLECULAR THERAPY, 23 (5). pp. 845-856.

Alonso-Camino, V, Rajani, K, Kottke, T, Rommelfanger-Konkol, D, Zaidi, S, Thompson, J, Pulido, J, Ilett, E, Donnelly, O, Selby, P, Pandha, H, Melcher, A, Harrington, K, Diaz, RM and Vile, R (2014) The Profile of Tumor Antigens Which Can be Targeted by Immunotherapy Depends Upon the Tumor's Anatomical Site MOLECULAR THERAPY, 22 (11). pp. 1936-1948.

Ilett, E, Kottke, T, Donnelly, O, Thompson, J, Willmon, C, Diaz, R, Zaidi, S, Coffey, M, Selby, P, Harrington, K, Pandha, H, Melcher, A and Vile, R (2014) Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic Virus MOLECULAR THERAPY, 22 (10). pp. 1851-1863.

Jennings, VA, Ilett, EJ, Scott, KJ, West, EJ, Vile, R, Pandha, H, Harrington, K, Young, A, Hall, GD, Coffey, M, Selby, P, Errington-Mais, F and Melcher, AA (2014) Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites INTERNATIONAL JOURNAL OF CANCER, 134 (5). pp. 1091-1101.

Pulido, J, Kottke, T, Thompson, J, Galivo, F, Wongthida, P, Diaz, RM, Rommelfanger, D, Ilett, E, Pease, L, Pandha, H, Harrington, K, Selby, P, Melcher, A and Vile, R (2012) Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma Nature Biotechnology, 30 (4). pp. 337-343.

Kottke, T, Chester, J, Ilett, E, Thompson, J, Diaz, R, Coffey, M, Selby, P, Nuovo, G, Pulido, J and Mukhopadhyay, D (2011) Precise scheduling of chemotherapy primes VEGF-producing tumors for successful systemic oncolytic virotherapy. Mol Ther, 19 (10). pp. 1802-1812.

Kottke, T, Errington, F, Pulido, J, Galivo, F, Thompson, J, Wongthida, P, Diaz, RM, Chong, H, Ilett, E, Chester, J, Pandha, H, Harrington, K, Selby, P, Melcher, A and Vile, R (2011) Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors. Nat Med, 17 (7). pp. 854-859.

Ilett, EJ, Barcena, M, Errington-Mais, F, Griffin, S, Harrington, KJ, Pandha, HS, Coffey, M, Selby, PJ, Limpens, RWAL, Mommaas, M, Hoeben, RC, Vile, RG and Melcher, AA (2011) Internalization of Oncolytic Reovirus by Human Dendritic Cell Carriers Protects the Virus from Neutralization CLINICAL CANCER RESEARCH, 17 (9). pp. 2767-2776.

Steele, L, Errington, F, Prestwich, R, Ilett, E, Harrington, K, Pandha, H, Coffey, M, Selby, P, Vile, R and Melcher, A (2011) Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-kappa B mediated and supports innate and adaptive anti-tumour immune priming MOLECULAR CANCER, 10, ARTN 20.

Prestwich, RJ, Errington, F, Steele, LP, Ilett, EJ, Morgan, RSM, Harrington, KJ, Pandha, HS, Selby, PJ, Vile, RG and Melcher, AA (2009) Reciprocal Human Dendritic Cell-Natural Killer Cell Interactions Induce Antitumor Activity Following Tumor Cell Infection by Oncolytic Reovirus JOURNAL OF IMMUNOLOGY, 183 (7). pp. 4312-4321.

Prestwich, RJ, Ilett, EJ, Errington, F, Diaz, RM, Steele, LP, Kottke, T, Thompson, J, Galivo, F, Harrington, KJ, Pandha, HS, Selby, PJ, Vile, RG and Melcher, AA (2009) Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication CLINICAL CANCER RESEARCH, 15 (13). pp. 4374-4381.

Ilett, EJ, Prestwich, RJ, Kottke, T, Errington, F, Thompson, JM, Harrington, KJ, Pandha, HS, Coffey, M, Selby, PJ, Vile, RG and Melcher, AA (2009) Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity GENE THERAPY, 16 (5). pp. 689-699.

Prestwich, RJ, Errington, F, Ilett, EJ, Morgan, RSM, Scott, KJ, Kottke, T, Thompson, J, Morrison, EE, Harrington, KJ, Pandha, HS, Selby, PJ, Vile, RG and Melcher, AA (2008) Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity CLINICAL CANCER RESEARCH, 14 (22). pp. 7358-7366.

Conference or Workshop Item

Zaidi, S, Blanchard, M, Shim, K, Ilett, E, Kottke, T, Thompson, J, Celis, E, Pandha, H, Selby, P, Melcher, A, Harrington, K and Vile, R (2014) Acquisition of Mutated BRAF Is as a Major Effector of Melanoma Recurrence Which Can Be Targeted By Immuno- or Chemo-Therapy In: 17th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 2014-05-21 - 2014-05-24, Washington, DC.

Ilett, E, Kottke, T, Donnelly, O, Thompson, J, Willmon, C, Diaz, R, Zaidi, S, Coffey, M, Selby, P, Harrington, K, Pandha, H, Melcher, A and Vile, R (2014) Direct, Cytokine-Conditioned, In Vivo Cell Loading for Systemic Delivery of Oncolytic Viruses In: 17th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 2014-05-21 - 2014-05-24, Washington, DC.

Kottke, T, Donnelly, O, Ilett, E, Thompson, J, Diaz, R, Coffey, M, Selby, P, Pandha, H, Harrington, K, Melcher, A and Vile, R (2013) In Vivo Expansion of a Recipient Population of Cell Carriers Allows for Highly Effective Systemic Delivery of Oncolytic Reovirus Even in the Presence of Neutralizing Antibody In: 16th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 2013-05-15 - 2013-05-18, Salt Lake City, UT.

This list was generated on Sat Nov 18 12:10:10 2017 UTC.

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800